What to watch for at ACOG 2022, according to past president Eva Chalas, MD

The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.

Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.

Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.

Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.

Before prescribing testosterone, know what the evidence actually proves. Maria Uloko, MD, draws a sharp line between the one population the data supports and the much wider group of women asking about it.

Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.

David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.

SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.